Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BBIO |
---|---|---|
09:32 ET | 211732 | 29 |
09:33 ET | 237216 | 29.26 |
09:35 ET | 333761 | 29.865 |
09:37 ET | 175193 | 29.645 |
09:39 ET | 240181 | 30.015 |
09:42 ET | 228119 | 30.097 |
09:44 ET | 100559 | 30.065 |
09:46 ET | 149192 | 29.89 |
09:48 ET | 136988 | 29.83 |
09:50 ET | 84351 | 29.2101 |
09:51 ET | 167419 | 28.66 |
09:53 ET | 247007 | 28.825 |
09:55 ET | 85061 | 28.86 |
09:57 ET | 175540 | 29 |
10:00 ET | 67039 | 29.5225 |
10:02 ET | 74461 | 29.25 |
10:04 ET | 97792 | 29.43 |
10:06 ET | 86024 | 29.59 |
10:08 ET | 48864 | 29.805 |
10:09 ET | 50550 | 29.75 |
10:11 ET | 151404 | 29.77 |
10:13 ET | 108967 | 29.7309 |
10:15 ET | 57076 | 29.755 |
10:18 ET | 133674 | 29.835 |
10:20 ET | 135032 | 29.98 |
10:22 ET | 64714 | 30.01 |
10:24 ET | 60807 | 29.94 |
10:26 ET | 143576 | 30.12 |
10:27 ET | 132979 | 30.002 |
10:29 ET | 39994 | 30.14 |
10:31 ET | 92990 | 30.36 |
10:33 ET | 186599 | 30.43 |
10:36 ET | 67821 | 30.235 |
10:38 ET | 54444 | 29.986 |
10:40 ET | 37239 | 29.9 |
10:42 ET | 36521 | 29.765 |
10:44 ET | 25862 | 29.87 |
10:45 ET | 17804 | 29.855 |
10:47 ET | 36356 | 29.81 |
10:49 ET | 22155 | 29.83 |
10:51 ET | 21502 | 29.545 |
10:54 ET | 49076 | 29.56 |
10:56 ET | 20459 | 29.71 |
10:58 ET | 10972 | 29.68 |
11:00 ET | 13104 | 29.65 |
11:02 ET | 18590 | 29.815 |
11:03 ET | 17789 | 29.8 |
11:05 ET | 21202 | 29.73 |
11:07 ET | 22635 | 29.75 |
11:09 ET | 12804 | 29.58 |
11:12 ET | 63612 | 29.33 |
11:14 ET | 22268 | 29.31 |
11:16 ET | 34410 | 29.26 |
11:18 ET | 25176 | 29.14 |
11:20 ET | 51712 | 28.91 |
11:21 ET | 44085 | 29.15 |
11:23 ET | 38971 | 28.995 |
11:25 ET | 21987 | 28.955 |
11:27 ET | 14269 | 28.94 |
11:30 ET | 25351 | 29 |
11:32 ET | 9639 | 28.98 |
11:34 ET | 13846 | 28.99 |
11:36 ET | 142776 | 28.79 |
11:38 ET | 21624 | 28.975 |
11:39 ET | 23755 | 28.925 |
11:41 ET | 10434 | 28.92 |
11:43 ET | 26203 | 28.78 |
11:45 ET | 13687 | 28.57 |
11:48 ET | 42592 | 28.605 |
11:50 ET | 16329 | 28.545 |
11:52 ET | 55630 | 28.46 |
11:54 ET | 17049 | 28.53 |
11:56 ET | 13200 | 28.38 |
11:57 ET | 25209 | 28.57 |
11:59 ET | 19434 | 28.38 |
12:01 ET | 39691 | 28.245 |
12:03 ET | 38400 | 28.08 |
12:06 ET | 125670 | 27.995 |
12:08 ET | 72401 | 28.035 |
12:10 ET | 18685 | 27.98 |
12:12 ET | 24957 | 27.96 |
12:14 ET | 30055 | 28.01 |
12:15 ET | 19300 | 27.995 |
12:17 ET | 29345 | 28.09 |
12:19 ET | 17550 | 27.92 |
12:21 ET | 42043 | 27.885 |
12:24 ET | 29744 | 27.9 |
12:26 ET | 15437 | 27.885 |
12:28 ET | 50448 | 28.22 |
12:30 ET | 15514 | 28.18 |
12:32 ET | 10696 | 28.07 |
12:33 ET | 18533 | 28.12 |
12:35 ET | 10887 | 28.1084 |
12:37 ET | 51787 | 28.11 |
12:39 ET | 64346 | 27.9 |
12:42 ET | 59084 | 28.015 |
12:44 ET | 9585 | 27.94 |
12:46 ET | 36436 | 27.95 |
12:48 ET | 35966 | 28 |
12:50 ET | 36514 | 27.935 |
12:51 ET | 12536 | 27.8234 |
12:53 ET | 11477 | 27.8177 |
12:55 ET | 17702 | 27.81 |
12:57 ET | 14379 | 27.94 |
01:00 ET | 32259 | 28.065 |
01:02 ET | 20374 | 28.125 |
01:04 ET | 15797 | 28.135 |
01:06 ET | 17598 | 28.1754 |
01:08 ET | 12290 | 28.0711 |
01:09 ET | 9895 | 28.025 |
01:11 ET | 12021 | 27.9701 |
01:13 ET | 17003 | 27.99 |
01:15 ET | 22890 | 28 |
01:18 ET | 6236 | 27.85 |
01:20 ET | 14159 | 27.885 |
01:22 ET | 11067 | 27.88 |
01:24 ET | 6404 | 27.84 |
01:26 ET | 32309 | 27.74 |
01:27 ET | 17159 | 27.7 |
01:29 ET | 14269 | 27.7 |
01:31 ET | 26318 | 27.7982 |
01:33 ET | 10934 | 27.78 |
01:36 ET | 17398 | 27.53 |
01:38 ET | 22590 | 27.45 |
01:40 ET | 10636 | 27.24 |
01:42 ET | 20678 | 27.345 |
01:44 ET | 28497 | 27.55 |
01:45 ET | 7291 | 27.415 |
01:47 ET | 7411 | 27.45 |
01:49 ET | 7262 | 27.38 |
01:51 ET | 8940 | 27.33 |
01:54 ET | 4144 | 27.28 |
01:56 ET | 20565 | 27.182 |
01:58 ET | 55644 | 27.21 |
02:00 ET | 14642 | 27.23 |
02:02 ET | 55007 | 27.338 |
02:03 ET | 26916 | 27.5697 |
02:05 ET | 19591 | 27.56 |
02:07 ET | 27629 | 27.48 |
02:09 ET | 29363 | 27.4428 |
02:12 ET | 11257 | 27.38 |
02:14 ET | 8407 | 27.39 |
02:16 ET | 22083 | 27.32 |
02:18 ET | 17278 | 27.23 |
02:20 ET | 28640 | 27.265 |
02:21 ET | 8778 | 27.33 |
02:23 ET | 14483 | 27.3 |
02:25 ET | 16959 | 27.4206 |
02:27 ET | 13454 | 27.455 |
02:30 ET | 20166 | 27.445 |
02:32 ET | 34601 | 27.47 |
02:34 ET | 10730 | 27.32 |
02:36 ET | 9683 | 27.31 |
02:38 ET | 7723 | 27.23 |
02:39 ET | 15587 | 27.315 |
02:41 ET | 7535 | 27.445 |
02:43 ET | 11000 | 27.44 |
02:45 ET | 10002 | 27.45 |
02:48 ET | 15891 | 27.37 |
02:50 ET | 11477 | 27.36 |
02:52 ET | 3817 | 27.385 |
02:54 ET | 7310 | 27.36 |
02:56 ET | 49958 | 27.17 |
02:57 ET | 18181 | 27.33 |
02:59 ET | 7403 | 27.405 |
03:01 ET | 12455 | 27.3659 |
03:03 ET | 11868 | 27.225 |
03:06 ET | 10622 | 27.215 |
03:08 ET | 20156 | 27.24 |
03:10 ET | 27466 | 27.17 |
03:12 ET | 14278 | 27.2199 |
03:14 ET | 38548 | 27.3025 |
03:15 ET | 60188 | 27.405 |
03:17 ET | 13748 | 27.45 |
03:19 ET | 7727 | 27.34 |
03:21 ET | 16321 | 27.365 |
03:24 ET | 13023 | 27.399 |
03:26 ET | 27107 | 27.235 |
03:28 ET | 34124 | 27.09 |
03:30 ET | 16392 | 27.11 |
03:32 ET | 16437 | 27.205 |
03:33 ET | 14766 | 27.2392 |
03:35 ET | 21902 | 27.215 |
03:37 ET | 12280 | 27.205 |
03:39 ET | 17982 | 27.16 |
03:42 ET | 33659 | 27.17 |
03:44 ET | 21804 | 27.185 |
03:46 ET | 71169 | 26.98 |
03:48 ET | 110646 | 27.0186 |
03:50 ET | 25614 | 26.975 |
03:51 ET | 57967 | 27.0699 |
03:53 ET | 35574 | 27.165 |
03:55 ET | 39063 | 27.185 |
03:57 ET | 74757 | 27.165 |
04:00 ET | 851181 | 27.19 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
BridgeBio Pharma Inc | 4.4B | -11.3x | --- |
Biohaven Ltd | 4.5B | -4.8x | --- |
Immunovant Inc | 3.9B | -12.1x | --- |
Crinetics Pharmaceuticals Inc | 5.0B | -15.1x | --- |
Avidity Biosciences Inc | 5.2B | -15.5x | --- |
Immunitybio Inc | 3.6B | -5.8x | --- |
BridgeBio Pharma, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on discovering, creating, testing and delivering transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. The Company's pipeline of development programs ranges from early science to advanced clinical trials that include Acoramidis (AG10), a next-generation small molecule near-complete transthyretin (TTR) stabilizer, for the treatment of amyloidosis TTR (ATTR); low-dose infigratinib, an oral FGFR1-3 selective tyrosine kinase inhibitor (TKI), as a treatment option for children with achondroplasia; Encaleret, a small molecule antagonist of the calcium sensing receptor (CaSR) for the treatment of Autosomal Dominant Hypocalcemia Type 1 (ADH1), and BBP-418, an investigational, orally administered, small molecule substrate supplementation therapy that the Company is developing for the treatment of LGMD2I, also known as LGMDR9.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.4B |
---|---|
Revenue (TTM) | $217.8M |
Shares Outstanding | 188.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.04 |
EPS | $-2.41 |
Book Value | $-7.73 |
P/E Ratio | -11.3x |
Price/Sales (TTM) | 20.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -180.30% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.